TCM

TCG Crossover Management Portfolio holdings

AUM $876M
This Quarter Return
+47.15%
1 Year Return
+23.66%
3 Year Return
+996.72%
5 Year Return
–
10 Year Return
–
AUM
$876M
AUM Growth
+$876M
Cap. Flow
-$231M
Cap. Flow %
-26.38%
Top 10 Hldgs %
56.33%
Holding
40
New
2
Increased
1
Reduced
6
Closed
2

Top Buys

1
AGIO icon
Agios Pharmaceuticals
AGIO
$23.2M
2
DYN icon
Dyne Therapeutics
DYN
$10.6M
3
ELVN icon
Enliven Therapeutics
ELVN
$9.99M

Top Sells

1
NKTR icon
Nektar Therapeutics
NKTR
$96.5M
2
RAPT icon
RAPT Therapeutics
RAPT
$91.6M
3
MLYS icon
Mineralys Therapeutics
MLYS
$39.2M
4
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
$21.7M
5
CMPS
Compass Pathways
CMPS
$11M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ELVN icon
26
Enliven Therapeutics
ELVN
$1.24B
$9.99M 1.14%
+498,000
New +$9.99M
MBX
27
MBX Biosciences, Inc. Common Stock
MBX
$490M
$7.42M 0.85%
650,000
– –
NKTR icon
28
Nektar Therapeutics
NKTR
$559M
$6.89M 0.79%
266,666
-3,733,334
-93% -$96.5M
VTGN icon
29
VistaGen Therapeutics
VTGN
$106M
$5.35M 0.61%
2,676,580
– –
KOD icon
30
Kodiak Sciences
KOD
$461M
$4.27M 0.49%
1,145,538
– –
KURA icon
31
Kura Oncology
KURA
$700M
$4.24M 0.48%
735,184
-688,458
-48% -$3.97M
TRDA icon
32
Entrada Therapeutics
TRDA
$207M
$3.93M 0.45%
584,955
– –
ADVM icon
33
Adverum Biotechnologies
ADVM
$65.3M
$3.86M 0.44%
1,796,482
– –
AVTX icon
34
Avalo Therapeutics
AVTX
$117M
$2.41M 0.28%
483,000
– –
VTYX icon
35
Ventyx Biosciences
VTYX
$175M
$677K 0.08%
316,195
– –
JBIO
36
Jade Biosciences, Inc. Common Stock
JBIO
$254M
$640K 0.07%
64,023
-2,176,786
-97% -$21.7M
CABA icon
37
Cabaletta Bio
CABA
$133M
$132K 0.02%
86,795
– –
CMPS
38
Compass Pathways
CMPS
$437M
– –
-3,858,000
Closed -$11M
KROS icon
39
Keros Therapeutics
KROS
$637M
– –
0
– –
MLYS icon
40
Mineralys Therapeutics
MLYS
$1.97B
– –
-2,470,265
Closed -$39.2M
1
2